NIH Clinical Center Search the Studies: Study Number, Study Title

Protocol Details

Collection of Serum and Tissue Samples from Patients with Biopsy-Proved or Suspected Malignant Diseases

This study is currently recruiting participants.

Summary | Eligibility | Citations | Contacts

Summary

Number

97-C-0147

Sponsoring Institute

National Cancer Institute (NCI)

Recruitment Detail

Type: Participants currently recruited/enrolled
Gender: Male & Female
Min Age: 2 Years
Max Age: N/A

Referral Letter Required

No

Population Exclusion(s)

None

Keywords

Serum;
Collection of Tissue;
Malignant Disease;
Molecular Basis;
Genome Sequencing;
Natural History

Recruitment Keyword(s)

None

Condition(s)

Malignant Neoplasms;
Hereditary Neoplastic syndromes;
Kidney Cancer;
Renal Cancer;
Bladder Cancer

Investigational Drug(s)

None

Investigational Device(s)

None

Intervention(s)

None

Supporting Site

National Cancer Institute

Selected patients suspected of having or with prior biopsy proof of malignant disease will be seen in the Urologic Oncology Branch, NCI. Blood samples may be collected at the time of the initial visit and at periodic intervals during the course of the disease. These samples will be stored in the tissue bank of the Urologic Oncology Branch. Aliquots of malignant and normal tissue will be collected at the time of surgery and stored in the tissue bank, Urologic Oncology Branch, NCI. These materials will be used in the research efforts of the Urologic Oncology Branch, NCI.

--Back to Top--

Eligibility

INCLUSION CRITERIA:

- Adult and minor patients with biopsy-proven malignant disease

- Adult and minor patients suspected of having a malignant disease

- Patients who have or are suspected of having an inherited genitourinary malignant disorder

- Participants must be >= 2 years of age

- Family members (related by blood) of patients who have or are suspected of having a malignant disease or an inherited genitourinary malignant disorder.

-All patients and guardians, for children younger than 18 years of age, must sign an informed consent document indicating their understanding of the investigational nature and the risks of this study before any protocol related studies are performed. Patients under the age of 18 but who are age 13 or older will be asked to sign an assent document prior to participation.

EXCLUSION CRITERIA:

- Subjects whose co-morbidities preclude surgical intervention.


--Back to Top--

Citations:

Not Provided

--Back to Top--

Contacts:

Principal Investigator

Referral Contact

For more information:

W. Marston Linehan, M.D.
National Cancer Institute (NCI)
NIHBC 10 - CRC BG RM 1-5942
10 CENTER DR
BETHESDA MD 20892
(240) 858-3700
linehanm@mail.nih.gov

Deborah A. Nielsen, R.N.
National Cancer Institute (NCI)
National Institutes of Health
Building 10
Room 13N218
10 Center Drive
Bethesda, Maryland 20892
(240) 760-6247
deborah.nielsen@nih.gov

NCI Referral Office
National Institute of Health Clinical Center (CC), 9000 Rockville Pike, Bethesda, Maryland 20892, United States: NCI Clinical Trials Referral Office
1-888-NCI-1937

Clinical Trials Number:

NCT00026884

--Back to Top--